Glaukos (GKOS) Interest Coverage Ratio (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -205.39% |
| Dec 31, 2025 | 220.25% |
| Sep 30, 2025 | 29.35% |
| Jun 30, 2025 | -10.87% |
| Mar 31, 2025 | -144.28% |
| Dec 31, 2024 | 370.79% |
| Sep 30, 2024 | -65.98% |
| Jun 30, 2024 | 21.10% |
| Mar 31, 2024 | -0.50% |
| Dec 31, 2023 | -36.68% |
| Sep 30, 2023 | 3.63% |
| Jun 30, 2023 | 11.64% |
| Mar 31, 2023 | 2.17% |
| Dec 31, 2022 | -59.39% |
| Sep 30, 2022 | 42.34% |
| Jun 30, 2022 | -475.63% |
| Mar 31, 2022 | 154.93% |
| Dec 31, 2021 | -261.57% |
| Sep 30, 2021 | 175.08% |
| Jun 30, 2021 | -17.67% |
| Mar 31, 2020 | -112.99% |
| Dec 31, 2019 | 23.72% |
| Sep 30, 2019 | -165.51% |
| Jun 30, 2019 | 201.26% |
| Mar 31, 2019 | -509.07% |
| Dec 31, 2018 | 123.12% |
| Sep 30, 2018 | -1,067.24% |
| Jun 30, 2018 | -136.73% |
| Mar 31, 2018 | 1,361.38% |
| Dec 31, 2017 | -102.09% |
| Sep 30, 2017 | 90.08% |
| Jun 30, 2017 | -67.64% |
| Mar 31, 2017 | 3,472.65% |
| Dec 31, 2016 | -94.69% |
| Sep 30, 2016 | -18.02% |
| Jun 30, 2016 | 358.61% |
| Mar 31, 2016 | 197.78% |
| Dec 31, 2015 | 35.75% |
| Sep 30, 2015 | 47.24% |
| Jun 30, 2015 | -317.33% |
| Mar 31, 2015 | 80.62% |
| Dec 31, 2014 | -163.06% |
| Sep 30, 2014 | 15.75% |